SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular

Kehua Pan1, Xince Huang2, Xiufen Jia1

  • 1Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.

Oncology Letters
|May 10, 2021
PubMed

Insights

Secreted protein acidic and rich in cysteine (SPARC) acts as an oncogene in most cancers, including pancreatic adenocarcinoma (PAAD). SPARC promotes PAAD cell proliferation and migration, correlating with poor patient prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Secreted protein acidic and rich in cysteine (SPARC) has a complex role in tumor development, with conflicting evidence on its oncogenic or tumor-suppressive functions.
  • SPARC's dual role necessitates further investigation, particularly in pancreatic adenocarcinoma (PAAD), where its therapeutic potential is being explored.

Purpose of the Study:

  • To conduct a pan-cancer analysis of SPARC expression and function.
  • To investigate the specific role of SPARC in pancreatic adenocarcinoma (PAAD) pathogenesis and its association with patient prognosis.

Main Methods:

  • Pan-cancer analysis utilizing The Cancer Genome Atlas (TCGA) data.
  • In vitro experiments assessing the impact of SPARC on PAAD cell proliferation and migration (PANC-1 and SW1990 cell lines).
  • Detection of SPARC in cell culture supernatants.

Main Results:

  • SPARC functions as an oncogene in most cancer types but as a tumor suppressor in others.
  • SPARC expression is significantly upregulated in PAAD and linked to poorer patient outcomes.
  • SPARC enhances PAAD cell proliferation and migration in vitro, particularly when secreted extracellularly.

Conclusions:

  • SPARC's role is context-dependent, varying with tumor type.
  • SPARC acts as a significant oncogene in pancreatic adenocarcinoma (PAAD).
  • SPARC's extracellular function in PAAD highlights its importance in tumor progression and suggests potential as a therapeutic target.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
50.0K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K